<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Miyoshi <z:hpo ids='HP_0003198'>myopathy</z:hpo> is the most common form of recessive distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>Recessive mutations in the ANO5 gene have been recently identified in Northern Europe as a cause of non dysferlin-linked distal <z:hpo ids='HP_0003198'>myopathy</z:hpo> and <z:hpo ids='HP_0006785'>limb girdle muscular dystrophy</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>We report here the first French cases of anoctamin 5 <z:hpo ids='HP_0003198'>myopathy</z:hpo> in 2 brothers presenting with a Miyoshi-like pattern </plain></SENT>
<SENT sid="3" pm="."><plain>Comparing these patients with 12 other cases from the literature shows that <z:hpo ids='HP_0000001'>all</z:hpo> cases share a homogeneous clinical pattern, characterized by initial calf muscles involvement </plain></SENT>
<SENT sid="4" pm="."><plain>Asymmetric <z:hpo ids='HP_0003202'>muscle atrophy</z:hpo> often precedes <z:mp ids='MP_0000746'>weakness</z:mp> </plain></SENT>
<SENT sid="5" pm="."><plain>In this setting, high CK level and <z:mpath ids='MPATH_458'>normal</z:mpath> expression of dysferlin in muscle should lead to consider the diagnosis, which will be confirmed by ANO5 gene testing </plain></SENT>
<SENT sid="6" pm="."><plain>The c.191dupA mutation, already reported as a <z:e sem="disease" ids="C0263541" disease_type="Disease or Syndrome" abbrv="">founder</z:e> mutation in Caucasian patients with anoctamin <z:hpo ids='HP_0003198'>myopathies</z:hpo>, was found in our family in a heterozygous state </plain></SENT>
</text></document>